TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 126 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2017. The put-call ratio across all filers is 9.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,775,000 | -4.8% | 45,604 | +2.5% | 0.08% | -16.7% |
| Q3 2017 | $5,016,000 | +68.3% | 44,511 | +67.3% | 0.09% | +42.9% |
| Q2 2017 | $2,981,000 | +29.8% | 26,604 | +35.2% | 0.06% | +23.5% |
| Q1 2017 | $2,296,000 | +6.0% | 19,681 | -4.3% | 0.05% | -22.7% |
| Q4 2016 | $2,166,000 | +48.3% | 20,570 | +55.6% | 0.07% | +22.2% |
| Q3 2016 | $1,461,000 | +46.8% | 13,222 | +93.5% | 0.05% | 0.0% |
| Q2 2016 | $995,000 | +34.8% | 6,833 | +32.6% | 0.05% | +17.4% |
| Q1 2016 | $738,000 | -74.6% | 5,152 | -72.6% | 0.05% | -79.6% |
| Q4 2015 | $2,904,000 | +463.9% | 18,793 | +421.4% | 0.22% | +174.4% |
| Q3 2015 | $515,000 | -90.0% | 3,604 | -89.9% | 0.08% | -60.0% |
| Q2 2015 | $5,149,000 | -6.8% | 35,837 | -8.5% | 0.20% | -7.2% |
| Q1 2015 | $5,526,000 | +98.6% | 39,181 | +108.6% | 0.22% | +53.5% |
| Q4 2014 | $2,783,000 | – | 18,780 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |